Ignite Creation Date:
2024-10-26 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06561009
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-07-23
Brief Title:
Safety and Efficacy of BAFFR CART for Relapsed Refractory Neuromyelitis Optica Spectrum Disorder
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Safety and Efficacy of BAFFR CART for Relapsed Refractory Neuromyelitis Optica Spectrum Disorder
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is an open-label single-arm dose-escalation study in up to 20 participants with relapsedrefractory Neuromyelitis Optica Spectrum Disorders NMOSD The aim is to evaluate the safety and efficacy of the treatment with BAFFR CART
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None